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Abstract 
After filtration and ultrafiltration (10 kD) of 24 hour 
urine specimens from 12 healthy male subjects, calcium 
oxalate crystallization was induced in the filtered 
(FILTD) and ultrafiltered (UF) fractions by administra-
tion of a sodium oxalate load. In addition crystallization 
was also induced in UF fractions to which physiological 
quantities of chondroitin sulphate (CHON) had been 
added (UF + CHON). The rate of calcium oxalate crys-
tallization was determined by measuring the rate at 
which turbidity increased. Crystal numbers and sizes 
were measured with a Malvern particle size analyzer and 
by scanning electron microscopy. 
Crystallization rates, crystal numbers and crystal 
sizes were generally lower in UF fractions than in 
FIL TD fractions suggesting that urinary macromolecules 
are promoters of calcium oxalate crystallization. No in-
crease in crystallization rate, crystal numbers or sizes 
occurred when chondroitin sulphate was added to UF 
fractions, indicating that the promoter activity of urinary 
macromolecules is not due to this particular glycosamin-
oglycan. On the contrary, crystallization rates were 
qualitatively lower in UF + CHON fractions than in UF 
fractions alone, suggesting a possible inhibitory role for 
chondroitin sulphate in real urine. Scanning electron 
microscopy revealed that while aggregates were present 
in UF and FILTD fractions, they were absent in UF + 
CHON fractions. This observation indicates that chon-
droitin sulphate might be an inhibitor of calcium oxalate 
crystal aggregation in real urine. 
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phate, calcium oxalate, crystallization, inhibitors, pro-
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Introduction 
The role of urinary macromolecules (UMM) in 
promoting or inhibiting calcium oxalate (CaOx) uro-
lithiasis has been the subject of intensive investigation in 
recent years. Although several kinds of crystallization 
systems have been employed in such studies, two main 
approaches have been applied with respect to UMM in 
solution. The first of these has been to examine the col-
lective effect of UMM within certain molecular weight 
(MW) ranges. This has been achieved by removal or 
concentration of UMM by methods such as ultrafiltra-
tion, followed by various crystallization experiments in-
volving the ultrafiltrate or the retentate or both [ 1, 2, 5, 
6, 7, 9, 12, 17, 20, 21, 25, 30]. Conclusions in these 
experiments are thus based on observations recorded in 
the absence or presence of the entire range of UMM 
which has been excluded or included as a result of the 
particular procedures employed. In the second ap-
proach, individual UMM have been added to real or 
synthetic urines and their effects on subsequent crystalli-
zation processes have been monitored [3, 5, 8, 10, 11, 
13, 16, 18, 19, 22, 23, 24, 26, 27, 29, 34]. 
Unfortunately, neither approach has yielded consis-
tent results. For example, some studies involving the 
collective effect of UMM have found them to be inhibi-
tors of CaOx crystal formation [l, 2, 6, 7, 9, 17, 21] 
while others have found them to be promoters [5, 25]. 
In some cases, a dual promotion-inhibition role affect-
ing different crystallization mechanisms (nucleation and 
growth) have been reported [12, 20, 30]. 
Similarly, contradictory roles have been advocated 
for individual macromolecules. For example, Tamm-
Horsfall mucoprotein has been reported as being a pro-
moter [5, 12, 24, 34] and inhibitor [8, 12, 29, 34] of 
CaOx crystallization and is the subject of a review which 
addresses this very anomaly [14]. Another example is 
afforded by chondroitin sulphate (CHON) which is the 
most abundantly occurring glycosaminoglycan in urine 
[32]. Most studies involving this urinary macromolecule 
are in agreement that it is an inhibitor of CaOx crystal 
growth [3, 8, 18, 22, 23] and an inhibitor of CaOx crys-
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tal aggregation [3, 10, 22, 23, 27]. However, there 
have been other reports showing that CHON is not an 
inhibitor of aggregation [18], but is, a promoter of 
growth [16], an inhibitor of nucleation [16], and a 
promoter of nucleation [23]. Moreover, it is noted that 
all of these studies, including those which are in agree-
ment that CHON is an inhibitor of growth and aggre-
gation have been limited to investigations in inorganic 
solutions. It is interesting that studies using real urines 
have failed to find any inhibitory activity that could be 
attributed to this urinary macromolecule [11, 26]. How-
ever, a recent study involving urine-derived CHON has 
demonstrated enhancement of CaOx crystal nucleation in 
urine ultrafiltrates [31]. 
In the present study, aspects of both the "collective" 
and "individual" approaches were applied to a series of 
real urines. The first objective was to examine how the 
crystallization of CaOx in real urine would be affected 
by removal of UMM of MW > 10 kD (kilo-Daltons). 
The second objective was to investigate the extent to 
which the addition of CHON to ultrafiltered (UF) frac-
tions could restore the properties of the latter to those of 
the original filtered (FILTD) urine. 
Materials and Methods 
Twenty-four hour urines were collected by each of 
12 healthy male subjects in the age group 23 to 46 years 
(mean age 26 years). Urines were collected in glass 
bottles and were stored at 4°C during the 24 hour 
period, a method that has been widely used in numerous 
studies [2, 6, 12, 21, 26, 27, 30]. No preservative was 
added. Particulate matter was removed by passing each 
specimen through a 74 µm sieve, a Millipore AP prefil-
ter and a Sartorius cellulose acetate 0.45 µm filter. This 
urine fraction is henceforth referred to as FILTD. 
The limit of calcium oxalate metastability in each 
urine was determined by titration with sodium oxalate. 
In this method, successive samples of the particle-free 
urine (FILTD) at 38°C were inoculated with increasing 
concentrations of aqueous sodium oxalate (NaOx) until 
detectable crystallization occurred. The extent of crys-
tallization after each inoculation was measured by means 
of an AQUALYTIC AL 1000 turbidimeter while the 
metastable limit (MSL) itself was taken as the NaOx 
concentration at which the sudden increase in turbidity 
occurred (turbidity measurements are reported in terms 
of "turbidity units", tu). 
Particle-free urine specimens were ultrafiltered using 
an Amicon stirred ultrafiltration cell containing a Diaflo 
Type YMl0 membrane with a MW cut off of 10 kD. 
Nitrogen gas was used to maintain a pressure of 3. 7 atm 
(2812 torr) within the cell. Concentrations of low mo-
lecular mass ions and inhibitors were assumed to have 
been unaffected by ultrafiltration since Edyvane et al. 
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[6] have established that calcium, magnesium, phos-
phate, oxalate, urate, pyrophosphate and citrate concen-
trations remain unchanged after this procedure. 
Calcium oxalate crystallization was induced in the 
FILTD and UF fractions at 38°C by inoculation with 
NaOx corresponding to the previously determined MSL 
of the former. By administering the same NaOx load to 
each fraction in this way, we could effectively compare 
the crystallization response of each to this challenge. In 
addition, CHON (sodium salt, type A; Sigma Chemical 
Co.) was added to UF fractions which were then inocu-
lated with NaOx as before; the amount of CHON added 
was such that the final concentration of the salt was 10 
mg i-1 which is within the normal concentration range 
reported by Ryall et al. [27] for glycosaminoglycans in 
males. 
After inoculation with NaOx, the rate of calcium 
oxalate crystallization in each of the fractions FILTD, 
UF, and UF + CHON was measured by continuously 
monitoring the turbidity as a function of time. The rate 
at which turbidity increased (as determined from the gra-
dient of the linear portion of turbidity versus time 
graphs) was taken as the rate of CaOx crystallization. 
This is similar to the approach adopted by Ryall et al. 
[28] for their plots of particle volume vs time. Best fit 
straight lines were calculated by linear regression analy-
sis using interactive outlier rejection (Statgraphics, Ver-
sion 4, Statistical Graphics Corporation, U.S.A.). The 
Wilcoxon signed rank test was used to compare the crys-
tallization rates obtained from the slopes of these lines. 
A further assessment of the extent to which crystal-
lization occurred in each fraction was achieved by Mal-
vern particle size analysis [4]. The principle upon 
which this technique is based is that of light scattering 
by particles in a suspension. In the present study, the 
various fractions of each urine were inoculated with 
NaOx as previously described and particle numbers (per-
centage volume concentration - pvc) and particle sizes 
(volume mean diameter - vmd) were determined 120 
minutes thereafter. A MAL VERN 3600 EC particle size 
analyzer was used for this purpose. 
At the completion of each kinetic experiment (about 
90 minutes after administration of the NaOx load), each 
urine fraction was spun for 30 minutes in a Labofuge 
200 centrifuge (Heraeus) operating at 3500 revolutions 
per minute. The deposited crystals were removed by re-
peated aspiration using a Pasteur pipette. Drop amounts 
were filtered through a 0.2 µm Nucleopore filter (13 
mm diameter) supported in a Sartorius membrane filter 
clamp. Thereafter, filter papers, with deposited crystals, 
were pasted onto aluminium stubs. These were coated 
with approximately 100 nm of Au/Pd at a pressure of 
about 1.3 mPa in a Balzer's vacuum coater equipped 
with planetary sample rotator. Specimens, tilted at 35° 
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Table 1. Calcium oxalate crystalliz.ation rates (tu min-1) 
after addition of sodium oxalate. 
Sample no. UF 1 FILTD 1 UF+CHON 2 
1 0.03 0.13 0.03 
2 0.03 0.02 0.06 
3 0.02 0.02 0.01 
4 0.13 0.54 0.07 
5 0.09 0.44 0.04 
6 0.03 0.05 0.05 
7 0.19 0.34 0.04 
8 0.04 0.06 0.06 
9 0.12 0.42 0.04 
10 0.10 0.14 0.08 
11 0.01 0.06 0.01 
12 0.06 0.05 0.02 
1UF: ultrafiltrate; FILTD: Filtered; 
2UF +CHON: ultrafiltrate + chondroitin sulphate 
FILTD significantly greater than UF (p < 0.005); 
FILTD significantly greater than UF +CHON 
(p < 0.005); 
UF versus UF+CHON: no significant difference. 
to the collector, were examined using a Cambridge S200 
scanning electron microscope operating at an accelera-
ting voltage of 10 kV and a beam current of 100 µA. 
Results 
Calcium oxalate crystalliz.ation rates (as reflected by 
the rate at which turbidity increased) in UF, FIL TD and 
UF + CHON fractions are given in Table 1. It is noted 
that rates in FILTD fractions are significantly higher 
than in UF (p < 0.005) and UF+CHON (p < 0.005) 
fractions. There is no significant difference between UF 
and UF + CHON rates. 
For Malvern measurements, particle numbers (Table 
2) and particle sizes (Table 3) were indeterminately low 
in five UF and in six UF +CHON samples. However, 
finite values were obtained in all FILTD fractions. Be-
cause of the indeterminately low values, statistical analy-
ses of the Malvern data could not be performed. How-
ever, when fractions from the same urine are individu-
ally compared, it is seen that particle numbers in all 
FIL TD samples are greater than those in the correspond-
ing UF and UF + CHON fractions. No obvious trend in 
particle sizes (vmd values) were observed. 
Scanning electron microscopy (SEM) revealed sev-
eral noteworthy features in the various fractions. 
FILTD specimens were characterized by small quantities 
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Table 2. Malvern percentage volume concentrations 
(J>vc) after addition of sodium oxalate. 




4 0.0071 0.0209 
5 0.0387 
6 0.0039 0.0066 
7 0.0002 0.0087 
8 0.0037 0.0079 
9 0.0064 
10 0.0031 0.0125 
11 0.0004 0.0029 
12 0.0003 0.0053 








Table 3. Malvern volume mean diameters (µ.m) 











































of small, single, calcium oxalate dihydrate (COD) crys-
tals in the size range 5-10 µ.m (Fig. 1). Small aggre-
gates of COD crystals were occasionally observed (Fig. 
2). No calcium oxalate monohydrate (COM) deposits 
were detected. The quantity of COD crystals in UF 
fractions was either equal to or less than those in FILTD 
fractions. Crystal sizes were similar. However, aggre-
gates appeared more frequently in UF relative to 
FILTD; these consisted of crystals which were less than 
or equal to 10 µ.m in cross-section. Examples are shown 
in Figures 3 and 4. Another feature of UF fractions was 
the presence of small, oval-shaped COM deposits (Fig. 
A.L. Rodgers, D. Ball and W. Harper 
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Figure 1. Single COD crystals, typical of those 
observed in FILTD urines after inoculation with NaOx. 
Figure 2. Small aggregate of COD crystals, typical of 
those observed in FIL TD fractions after inoculation with 
NaOx. 
Figure 3. Aggregate of COD crystals, typical of those 
which were frequently observed in UF fractions after 
inoculation with NaOx. 
Figure 4. Star-shaped aggregate of COD crystals in 
contact with an aggregate of smaller COD crystals 
observed in UF fraction after inoculation with NaOx. 
Figure 5. Individual and aggregated COD crystals as 
well as small oval-shaped COM crystals typical of those 
observed in UF fractions after inoculation with NaOx. 
Urinary macromolecules and crystallization 
5). UF + CHON fractions showed the presence of fewer 
crystals than in the other fractions; these were small, 
single and COD. 
Discussion 
The turbidity data clearly show that removal of 
UMM (MW > 10 kD) from undiluted urine results in 
decreased crystallization rates in UF fractions and that 
addition of CHON to the latter does not restore its crys-
tallization potency. It is therefore concluded that, col-
lectively, UMM (MW > 10 kD) are promoters of calci-
um oxalate crystallization (in agreement with the find-
ings of other workers [5, 20, 25, 30]) and further, that 
CHON is not independently responsible for this promo-
tion. Of course, CHON might behave in a totally differ-
ent manner if other UMM's were present. Further ex-
periments involving the re-addition of all removed UMM 
are required to resolve this question. 
In addition, the potential role of Tamm-Horsfall 
mucoprotein (THM) must be considered. Although our 
filtration procedures will have removed the polymerized 
form of the mucoprotein [33], the possibility exists that 
other forms of THM might have been allowed to pass 
through. However, it is noted that other workers [12, 
26], like ourselves, have not taken this possibility into 
account. The role of the THM which might not have 
been eliminated by filtration will also have been in-
fluenced by the ionic strength of our urine samples [14]. 
Since the latter were all obtained from normal male sub-
jects and were not chemically tampered with, their ionic 
strengths are likely to have been fairly constant [15]. 
Further consideration of the results in Table 1 re-
veals that in 9 of the 12 samples, crystallization rates in 
UF + CHON fractions are either equal to, or less than 
those in UF fractions. Although these differences are 
not statistically significant, the qualitative trend suggests 
that CHON is an inhibitor of CaOx crystallization. The 
fact that particles could not be detected by Malvern tech-
niques in several UF and UF +CHON samples, while fi-
nite counts (Table 2) and sizes (Table 3) were registered 
in FILTD samples, may be interpreted as qualitative 
support for our conclusions that UMM (MW > 10 kD) 
are promoters of CaOx crystallization and that CHON 
does not independently contribute towards this process. 
Our SEM studies indicate that the number of single 
crystals deposited in the various fractions increased in 
the sequence UF+CHON < UF < FILTD. This is in 
agreement with our Malvern data which showed that 
FILTD fractions contained detectable particle numbers 
while the other fractions (UF and UF + CHON) did not 
(Table 2) and thus supports our hypotheses that UMM 
are promoters of CaOx crystallization and that CHON 
macromolecules are inhibitors. Crystal sizes, as ob-
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served by SEM were found to be similar in all fractions 
and is thus in qualitative agreement with our vmd data. 
The appearance of aggregates in both UF and 
FIL TD fractions is noteworthy since, on one band, it 
contradicts studies which have reported that UMM, col-
lectively, are inhibitors of aggregation in inorganic solu-
tions [17] and real urine [6, 26]. The latter studies, 
both from the same laboratory, also provide supportive 
SEM evidence. On the other hand, however, aggregates 
did appear more frequently in the UF fractions thereby 
lending support to these studies. 
Of some importance in our SEM studies is the ob-
servation of single (as opposed to aggregated) crystals in 
the UF + CHON fractions as it indicates that CHON may 
be an inhibitor of CaOx aggregation in real urine. Men-
tion has already been made of the fact that such a role 
for CHON has been demonstrated in inorganic solutions 
[3, 10, 22, 23, 27] but not in real urine [11, 26]. 
However, our results in this context are merely specula-
tive as it can be conversely argued that since crystal 
numbers decrease in the presence of CHON, the proba-
bility of secondary aggregation will also decrease. 
Thus, the absence of aggregates is not necessarily a 
direct consequence of inhibition of aggregation. 
Another SEM feature worthy of comment is the ap-
pearance of COM crystals in UF fractions. We are not 
sure of the significance of this observation but suggest 
that it might be related to slower crystallization rates in 
these fractions culminating in the formation of the ther-
modynamically most stable hydrate. It is noted that, al-
though COM crystals have been observed in other stud-
ies [6, 26], no inferences were drawn by those authors. 
An aspect of the present study that deserves com-
ment concerns our use of a commercial preparation of 
CHON. Since degree of sulphation and charge density 
can influence the role played by this glycosoaminoglycan 
in CaOx crystallization processes, it is recognized that 
it would be more meaningful to use chondroitin fractions 
isolated from fresh human urine. However, despite this, 
it is noted that commercial products have been widely 
used by other workers [10, 11, 19, 27, 29]. 
The results of this study have thus shown that UMM 
(MW > 10 kD) are promoters of CaOx crystallization 
and that CHON does not contribute towards this promo-
tion. On the contrary, there is independent evidence 
(turbidity, Malvern, and SEM) to suggest that this glyco-
saminoglycan may play an inhibitory role in CaOx crys-
tallization processes in real urine. 
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Discussion with Reviewers 
W.G. Robertson: What are the counting limitations of 
the Malvern 3600 EC Particle Sizer both in terms of 
particle diameter and slurry density? 
Authors: The lower detection limit for particle diam-
eter is 1.9 µm. Thus, "indeterminately low values" re-
ferred to in Tables 2 and 3 correspond to particles 
smaller than 1.9 µm. The Malvern does not give values 
for the slurry density. However, obscuration values are 
directly related to the latter and analyses are restricted to 
suspensions in which this value lies between 0.05 and 
0.3. In this way, multiple scattering can be regarded as 
insignificant. 
W.G. Robertson: Why was calcium oxalate dihydrate 
the predominant crystal formed since, under conditions 
of high oxalate concentration, it is usually calcium 
oxalate monohydrate that is formed? 
Authors: In general, the products of crystallization de-
pend on a multitude of factors. Although high (endoge-
nous) oxalate concentrations produce the monohydrate, 
our experiments involved administration of an acute oxa-
late challenge which produced the dihydrate. Indeed, 
our experience is that this method of crystal induction 
always produces the dihydrate (as well as the trihydrate) 
while the monohydrate is seldom observed. Thus, the 
formation of the higher hydrates occurs very quickly but 
may transform to the thermodynamically more stable 
monohydrate with the passage of time. Perhaps, the 
transformation bad not commenced by the time we con-
ducted our SEM investigation. 
F. Grases: Is it possible to relate inhibitory effects of 
CHON with some particular value of urinary pH? If 
affirmative, how is this relation explained? 
Authors: We did not investigate the inhibitory potential 
of CHON as a function of pH. Indeed, it is likely that 
some relationship does exist between these two param-
eters. However, we elected to use each urine at its nat-
ural pH without any adjustment thereof. pH values for 
our subjects did not show significant variation thereby 
precluding a retrospective investigation of this point. 
F. Grases: Can the authors assign the inhibitory action 
of CHON to nucleation processes rather than to crystal 
growth inhibition? 
Authors: Yes. Since crystal numbers are lower when 
CHON is present, it can be postulated that CHON is an 
inhibitor of nucleation. In addition, turbidity is strongly 
dependent on particle number as opposed to particle 
size. Thus, our kinetic data also point to inhibition of 
nucleation. 

